The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

Clinicians have traditionally used clinicopathological (CP) factors to determine locoregional recurrence (LR) risk of breast cancer and have generated the IBTR! nomogram to predict the risk of ipsilateral breast tumor recurrence (IBTR). The 21-gene recurrence score (RS) assay was recently correlated...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaker, Nikhil G, Hoffman, Karen E, Stauder, Michael C, Shaitelman, Simona F, Strom, Eric A, Tereffe, Welela, Smith, Benjamin D, Perkins, George H, Huo, Lei, Munsell, Mark F, Pusztai, Lajos, Buchholz, Thomas A, Woodward, Wendy A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318826/
https://www.ncbi.nlm.nih.gov/pubmed/25674496
http://dx.doi.org/10.1186/s40064-015-0840-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318826/
https://www.ncbi.nlm.nih.gov/pubmed/25674496
http://dx.doi.org/10.1186/s40064-015-0840-y

Ejemplares similares